released in fall of 2000. Elissavet was released because of its broad adaptation, high yielding ability, high protein concentration, and good-end use quality in central and northern Greece. Elissavet was derived as a single plant selection, from an F 7 bulk population of the cross 'Joss Cambier'/'Emu'// 'Chiroca'/4/Ias 20//'Willet Enano'*3/'Narino 59'/3/'Kavko', of the 17th International Bread Wheat Screening Nursery of CIMMYT. CIMMYT recorded the cross number as CM66246-C-1M-1Y-1M-2Y-OM. The nursery was established the fall of 1983 in experimental fields at the Cereal Institute, located at Thermi-Thessaloniki. Single plant selections were made on the basis of short stem, lodging and disease resistance, early maturity, and fertile heads in the summer of 1984. Single heads from each selected plant were used to establish F 7:8 head rows of low density during the fall of the same year. On the basis of the same selection criteria, F 8 plants were selected from the visually best F 7:8 head rows the summer of 1985, and F 7:9 head rows of low density were sown during the fall of the same year. At harvest, seeds of nonselected plants were bulked from each group of selected F 7:8 head rows and were used to establish microtrials the autumn of 1985. Microtrials were composed of two row plots, 1.5 m long, and were established at two locations. The three national checks ('Vergina', 'Dio', and 'Yecora-S') were included in these trials as randomly repeated checks. On the basis of uniformity and the selection criteria described and supported by the microtrials, the best F
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.